Regulation of MMP-2 and TIMP-3 expression by uPA signal transduction system in human bone giant cell tumor     

XU Ruo-bing  WEN Jian-ming  ZHANG Meng  LV Chang-hai  XIAO Gang  ZHANG Wen-min  LIANG Hui-zhen 《园艺学报》2004,20(11):1982-1988

AIM: To study effects of urokinase-type plasminogen activator (uPA) signal transduction on expression of matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-3 (TIMP-3) in giant cell tumor of bone (GCT). METHODS: Expression of uPAR, MMP-2 and TIMP-3 in GCT tissue was detected by immunohistochemistry. Phosphorylation level of mitogen-activated protein kinase (p44) in uPA/uPAR signal pathway in cultured GCT cells was detected by immunoprecipitation. The expression of MMP-2 and TIMP-3 in cultured cells after treatment with uPA-ATF or anti-uPAR antibody was also detected by Western blotting. RESULTS: 1) Urokinase-type plasminogen activator receptor (uPAR) was positive on the cell membrane and in cytoplasm of some mononuclear stromal cells (MSCs) and multinucleated giant cells (MGCs); 2) MMP-2 was positive in the cytoplasm and on the cell membrane of almost all of MSCs and some of MGCs. The polar distribution of MMP-2 in the cytoplasm of MGCs was especially obvious; 3) The expression of TIMP-3 of some MSCs and MGCs in GCT was much lower than MMP-2. The positive signal also showed a prominent polarity; 4) After treatment with uPA-ATF, the phosphorylation level of p44 in GCT cultured cells was much higher than the control. Addition of anti-uPAR antibody in the cells remarkably down-regulated the phosphorylation level of p44 as compared with the control group, suggesting that uPA-ATF participates cell signal transduction and this reaction can be inhibited by anti-uPAR antibody; 5) uPA-ATF cell signal pathway up-regulated expression of MMP-2 and TIMP-3, while anti-uPAR antibody down-regulated the expression of MMP-2 and TIMP-3. CONCLUSION: These results demonstrate for the first time that uPA-ATF directly regulates the expression of MMP-2 and TIMP-3 by signal transduction pathway, and the over-expression of MMP-2 and TIMP-3 may play an important role in local osteolysis of GCT.  相似文献   

Relationship of p21^WAF1 gene polymorphisms with protein expression in breast carcinomas     

XIAO Ning-xin  LI Zhong-hong  JIN Yi  WANG Guo-qiang  SU Zu-lan 《园艺学报》2004,20(6):976-980

AIM: To investigate the relationship between p21^WAF1gene polymorphisms and protein expression in breast carcinoma. METHODS: Polymerase chain reaction single-strand conformation polymorphisms technique (PCR-SSCP) and immunohistochemical assay of S-P immunostaining technique were used to study polymorphisms of p21^WAF1 and protein expression respectively on the specimen of paraffin-embedded tissues in 100 cases of breast carcinomas and 40 benign breast diseases as control. RESULTS: Two p21^WAF1 gene polymorphisms were found in 18% (18/100) of breast carcinomas and 5% (2/40) of control samples. The difference between the two groups was statistically significant (χ²=3.94, P＜0.05). The positive immunohistochemical reaction of p21^WAF1 protein were found in 50% (50/100) of breast carcinomas and 12.5% (5/40) of control samples. The difference between the two groups was statistically significant (χ²=16.84, P＜0.01). The positive immunohistochemical reaction of p21^WAF1 protein were found in 100% (18/18) of breast carcinomas with p21^WAF1 gene polymorphisms and 39% (32/82) of no p21^WAF1 gene polymorphisms. The difference between two groups was statistically significant (χ²=21.95, P＜0.01). The p21^WAF1 gene polymorphisms were correlated with the protein expression in breast carcinomas (r=0.576, P＜0.01). CONCLUSION: p21^WAF1 gene polymorphisms may create the different copies of mRNA and may make relevant protein molecules.  相似文献   

Induction of tumor-specific cytotoxic T lymphocytes in vitro by dendritic cells pulsed with different glioma antigens     

ZHU Xin-mei  QIAO Jian  XIAO Bao-guo  LU Chuan-zhen 《园艺学报》2004,20(4):584-589

AIM: The goal of this study was to compare different methods for tumor antigen preparation, to observe the induction of tumor-specific cytotoxic T lymphocytes in rats by dendritic cells (DCs) pulsed with different tumor antigens. METHODS: The precursors of dendritic cells were isolated from bone marrow of rats, stimulated in vitro with recombinent rat granulocyte-macrophage colony-stimulating factor (rrGM-CSF) and interleukin-4 (rrIL-4). Then rat DCs were pulsed with C6 tumor cell antigens prepared with different methods: freeze-thaw, boiling or total protein extracted from ultrasonic crushed tumor cell. Subsequently primed DCs were cocultured with T lymphocytes isolated from spleen to induce CTL. Lymphocyte chemoattractant factor from DCs and cytokine IFN-γ release were determined by ELISA, the cytotoxicity of CTL was assayed by JAM test. RESULTS: DCs pulsed with boiled tumor cell in vitro induced an enhanced ability of T-cell proliferation and cytotoxic T lymphocyte activity.CONCLUSION: Our results demonstrated that DCs primed with boiled tumor cell may represent a method for inducing immune responses against the entire repertoire of tumor antigens of malignancies.  相似文献   

禽流感病毒夹心ELISA快速检测方法的研究   总被引：21，自引：1，他引：21  

肖运才  李自力  胡思顺  石德时  许青荣  程峰  刘梅  毕丁仁  王桂枝 《畜牧兽医学报》2004,35(5):536-541

以禽流感病毒(AIV)湖北分离株(H9N2亚型)提纯物为免疫原，制备出鸡抗AIV和兔抗AIV抗体，经用琼脂扩散法测得效价分别为1:32和1:16。以纯化的鸡抗AIVIgG为包被抗体，兔抗AIVIgG为第二抗体，建立了检测AIV抗原的夹心ELISA法。结果表明，鸡抗AIVIgG的最佳包被浓度为1μg/mL，兔抗AIV IgG的最适工作浓度为5μg/mL；对已知的阳性样品，用夹心ELISA法测得的病毒滴度比血球凝集滴度高16倍以上，且能检出其它亚型的禽流感病毒；与新城疫病毒、传染性支气管炎病毒、减蛋综合征病毒、传染性喉气管炎病毒、传染性法氏囊病病毒、鸡痘病毒、马立克氏病病毒等无交叉反应，说明本方法有很高的特异性及敏感性。对14个鸡场送检的、患有呼吸道疾病或有腹膜炎、眼炎、产蛋下降、怀疑为禽流感感染的病鸡进行了检测，结果有7个鸡场为阳性。本方法的建立为禽流感病鸡群的临床检验提供了一种方便、敏感、快速的检测方法。  相似文献   

第十九期鸡胚原始生殖细胞的冷冻保存     

肖小珺  蔡琳琳  秦洁  李碧春 《黑龙江畜牧兽医》2005,(2):7-9

采用Ficoll密度梯度离心,提取第 19期(孵化 72h)性腺中的PGCs,对其应用不同的冷冻保护液和不同的平衡方法进行冷冻保存,并于复苏后进行体外培养。复苏后的PGCS用台盼蓝染色检测其存活率,结果发现:从第 19期性腺中获取的PGCs在同一种冷冻保护液下,采用不同的平衡方法进行冷冻,对PGCs的存活率有显著影响(P<0.05)或极显著影响(P<0.01);平衡方法相同,在不同冷冻保护液之间存在显著(P<0.05)或极显著 (P<0.01)差异。PGCs经体外培养 24h后再进行冷冻保存,复苏后其存活率、体外培养存活时间均极显著(P<0.01)短于分离后直接冷冻的PGCs。  相似文献   

那西肽对生长肥育猪的作用效果及其在产品中的残留   总被引：7，自引：0，他引：7  

朱淑斌  魏国生 《畜牧与兽医》2005,37(2):16-18

选择32头30kg左右健康的二元杂交生长猪, 随机分为4组, 每组8头, 个体饲喂, 4组均喂相同的基础饲粮, 但添加不同饲用抗生素,分别是低、高剂量那西肽(10mg/kg、50mg/kg)、盐霉素(30mg/kg) 和对照。猪体重达90kg时, 分别按0、3和7d停药后屠宰, 检测那西肽在样品各器官中的残留量。结果表明: 那西肽可显著提高生长肥育猪的采食量和日增重(P<0 05), 但是对料重比的改善作用不明显; 当检测灵敏度为0 01mg/kg时, 在低、高剂量那西肽组猪的心脏、肝脏、肾脏和背最长肌中, 均未检出那西肽。  相似文献   

土耳其斯坦东毕吸虫肌动蛋白基因的克隆及其序列分析     

魏佳何国声  徐梅倩姚宝安 《中国兽医寄生虫病》2005,13(4):1-8

目的利用RT-PCR和RACE技术克隆土耳其斯坦东毕吸虫肌动蛋白基因全长序列并进行序列分析.方法根据日本血吸虫和曼氏血吸虫肌动蛋白基因的保守区设计引物,利用RT-PCR扩增出土耳其斯坦东毕吸虫的肌动蛋白基因的大片段,再结合RACE技术分别得到肌动蛋白的3＇端和5＇端,将三部分序列拼接后获得肌动蛋白基因的全长cDNA序列并进行序列分析.结果成功克隆了土耳其斯坦东毕吸虫肌动蛋白的全长cDNA并提交GenBank,登录号为DQ017265,核酸序列比对表明东毕吸虫肌动蛋白基因的核苷酸序列和日本血吸虫、曼氏血吸虫的同源性分别为90%和91%.结论土耳其斯坦东毕吸虫肌动蛋白的全长cDNA的克隆为进一步表达及其生物学性能的分析提供了理论基础.  相似文献   

HBV/HAV复合抗原基因在CHO细胞中的表达     

万家余  张玉静  张蕾  韩烨  高建邦  孙博兴  肖安东 《中国兽医学报》2005,25(3):273-275

为探讨HBV／HAV复合疫苗的可行性，利用DNA重组技术将HBsAg与HAW复合多表位抗原基因VPX进行融合，插入到真核表达质粒pVAX1多克隆位点，构建成核酸表达疫苗pVAX1／SVPX，将其转染CHO细胞。转染细胞培养48h后，进行RTPCR、Western-blot、ELISA分析，结果表明HBV／HAV复合抗原基因SVPX能够在CHO细胞内转录、表达，融合蛋白具有HBV和HAV抗原的特性。  相似文献   

猪2型圆环病毒核酸疫苗免疫效应研究   总被引：9，自引：0，他引：9  

宋云峰  肖少波  金梅林  张松林  陈焕春 《畜牧兽医学报》2005,36(10):1049-1054

PCR扩增PCV2 ORF2和BVP22基因。将ORF2基因克隆入真核表达载体pCDNA3．1（＋），构建了pCORF2作为核酸疫苗免疫小白鼠。同时将具有蛋白转导功能的BVP22基因分别克隆到ORF2基因的上游和下游，使二者融合表达，命名为pCORF2BVP22和pCBVP220RF2。分4组肌肉免疫BALB/c小白鼠，分别注射pCDNA3．1（＋）、pCORF2、pCORF2BVP22和pCBVP220RF2，共免疫2次，间隔2周，分别于首免后2周和二免后4周采血，ELISA法检测体液抗体。同时为在体外验证ORF2和BVP22基因的真核表达，将ORF2和BVP22基因分别克隆入pEGFP-N1载体，构建了pNORF2和pNBVP22，转染Hela细胞后在荧光显微镜下观察到了ORF2和BVP22在体外的瞬时高效表达。结果显示，通过两次免疫后，各疫苗组均产生了针对ORF2的体液抗体，同时证明BVP22可增强核酸疫苗的免疫效果，其中以BVP22在ORF2上游效果更好。本研究为防制猪2型圆环病毒感染提供了较为理想的侯选疫苗。  相似文献   

猪伪狂犬病基因缺失疫苗的制备、安全性、免疫原性、保存期测定及区域试验   总被引：3，自引：1，他引：3  

何启盖  方六荣  吴斌  刘正飞  吴美洲  肖少波  金梅林  陈焕春 《畜牧兽医学报》2005,36(10):1055-1063

为了提供有效的伪狂犬病疫苗，用鸡胚成纤维细胞扩大培养了PrV HB-98突变株（TK^-/gG^-/LacZ^＋），研制了伪狂犬病基因缺失疫苗，并对该疫苗经肌肉接种、经口等免疫途径的最小免疫剂量进行了测定，同时也对4批疫苗的安全性、效力、免疫期和保存期进行了检测；同时将4批疫苗用于免疫23个猪场的母猪、新生仔猪和育肥猪进行区域试验。测定结果表明，疫苗经上述两种途径接种对不同阶段猪的最小免疫剂量均为10^5.0 TCID50；10倍免疫剂量的疫苗对初生仔猪、15日龄仔猪和妊娠母猪是安全的，免疫猪能抵抗强毒的攻击；疫苗在4℃和-20℃下分别可保存6个月和12个月。对伪狂犬病毒抗体阴性的70日龄商品猪和种猪的免疫期为6个月。田间试验表明，4批猪伪狂犬病基因缺失疫苗安全有效，并可用于仔猪发病时的紧急接种。为猪伪狂犬病基因工程疫苗的制备与应用提供了有力的依据。  相似文献